kidney disease glp 1 GLP-1 receptor agonist versus DPP-4 inhibitor and and cardiovascular outcomes in clinical practice in type-2 diabetes GLP-1RA Cuts Cardiovascular and Kidney

A new retrospective study suggests that women with type 2 diabetes who used GLP-1 receptor agonists after being diagnosed with breast cancer had better overall survival than similar patients who did not receive these medications

The molecular mechanism of transport by the mitochondrial ADP/ATP carrier

Theres no way to tell whats causing blood in your stool without a thorough evaluation

Principal Care address one single high-risk, complex chronic condition expected to last at least three months, performed either by (a) the clinical staff directed by a physician or other qualified healthcare professional (QHP) or (b) by the physician or a QHP